Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
47.02
+1.02 (2.22%)
At close: Aug 19, 2026, 4:00 PM EDT
46.70
-0.32 (-0.68%)
After-hours: Aug 19, 2026, 7:30 PM EDT
Pulse Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 101.62 | 80.74 | 118.04 | 44.37 | 61.14 | 28.61 |
Cash & Short-Term Investments | 101.62 | 80.74 | 118.04 | 44.37 | 61.14 | 28.61 |
Cash Growth | -4.45% | -31.60% | 166.06% | -27.44% | 113.67% | 39.75% |
Receivables | 0.12 | 0.27 | - | - | - | 0.06 |
Inventory | 0.24 | 0.14 | - | - | - | 5.82 |
Prepaid Expenses | 3.72 | 2.28 | 1.41 | 0.96 | 1.01 | 2.13 |
Total Current Assets | 105.7 | 83.42 | 119.45 | 45.33 | 62.15 | 36.63 |
Property, Plant & Equipment | 6.45 | 7.06 | 8.32 | 8.78 | 10.02 | 11.25 |
Goodwill | 2.79 | 2.79 | 2.79 | 2.79 | 2.79 | 2.79 |
Other Intangible Assets | 0.22 | 0.58 | 1.22 | 1.89 | 2.55 | 3.22 |
Other Long-Term Assets | 0.4 | 0.69 | 0.68 | 0.37 | 0.37 | 0.37 |
Total Assets | 115.56 | 94.54 | 132.46 | 59.15 | 77.88 | 54.25 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.83 | 2.78 | 1.67 | 1.84 | 1.57 | 2.9 |
Accrued Expenses | 6.46 | 3.58 | 5.83 | 3.81 | 2.55 | 3.78 |
Short-Term Debt | - | - | - | - | - | 0.44 |
Current Portion of Long-Term Debt | - | - | - | - | 0.92 | - |
Current Portion of Leases | 1.69 | 1.57 | 1.36 | 1.06 | 0.9 | 0.77 |
Current Unearned Revenue | - | - | - | - | - | 0.02 |
Other Current Liabilities | - | - | 1.2 | - | 0.05 | 0.61 |
Total Current Liabilities | 10.98 | 7.92 | 10.06 | 6.71 | 5.98 | 8.52 |
Long-Term Debt | - | - | - | - | 65 | - |
Long-Term Leases | 5.09 | 5.96 | 7.54 | 8.09 | 9.14 | 10.04 |
Total Liabilities | 16.06 | 13.88 | 17.6 | 14.79 | 80.13 | 18.56 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.07 | 0.07 | 0.07 | 0.06 | 0.04 | 0.03 |
Additional Paid-In Capital | 605.95 | 543.87 | 505.3 | 381.22 | 292.42 | 271.86 |
Retained Earnings | -506.52 | -463.28 | -390.5 | -336.92 | -294.71 | -236.2 |
Shareholders' Equity | 99.5 | 80.66 | 114.86 | 44.36 | -2.25 | 35.69 |
Total Liabilities & Equity | 115.56 | 94.54 | 132.46 | 59.15 | 77.88 | 54.25 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6.77 | 7.53 | 8.9 | 9.14 | 75.96 | 11.25 |
Net Cash (Debt) | 94.85 | 73.21 | 109.14 | 35.22 | -14.82 | 17.36 |
Net Cash Growth | -3.32% | -32.93% | 209.87% | - | - | 90.42% |
Net Cash Per Share | 1.39 | 1.09 | 1.87 | 0.71 | -0.44 | 0.62 |
Filing Date Shares Outstanding | 71.32 | 67.99 | 67.27 | 55.23 | 37.59 | 29.8 |
Total Common Shares Outstanding | 70.8 | 67.84 | 65.93 | 55.14 | 37.24 | 29.72 |
Working Capital | 94.72 | 75.5 | 109.39 | 38.62 | 56.17 | 28.11 |
Book Value Per Share | 1.41 | 1.19 | 1.74 | 0.80 | -0.06 | 1.20 |
Tangible Book Value | 96.49 | 77.29 | 110.85 | 39.68 | -7.59 | 29.68 |
Tangible Book Value Per Share | 1.36 | 1.14 | 1.68 | 0.72 | -0.20 | 1.00 |
Machinery | - | 2.61 | 2.31 | 2.21 | 2.08 | 1.95 |
Construction In Progress | - | 0.01 | 0.03 | - | 0.02 | 0.19 |
Leasehold Improvements | - | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 |